REGN 250110 1060.00P (REGN250110P1060000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

REGN250110P1060000

Watchlist

0.00
0.000.00%

15min DelayClose Jan 8 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Wells Fargo Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Cuts Target Price to $900
Moomoo News4minutes ago · Ratings
Oppenheimer Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Cuts Target Price to $950
Moomoo News06:31 ET · Ratings
Express News | Regeneron Pharmaceuticals, Inc. : Wells Fargo Cuts Target Price to $900 From $1050
Reuters06:26 ET
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
Benzinga14:12 ET
Novo, Eli Lilly to Dominate Global Pharma Sales in 2025: Report
Seeking AlphaJan 9 08:56 ET
S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today
Kevin TraversJan 8 16:12 ET

Comments

韭菜变主力

Jan 7 23:51

$Regeneron Pharmaceuticals (REGN.US)$ This is in NDX and could benefit from the weakness of mega-cap tech stocks in the index.

韭菜变主力

Dec 31 16:47

$Regeneron Pharmaceuticals (REGN.US)$Nice. It’s quiet here and just broke the steep down trend.

10xStockPicks

Dec 15, 2024 18:30

A.i Predicts Big Pharma Will Soon Acquire Esperion Therapeutics for $12 to $16 A share, Current Price $2.25

$Esperion Therapeutics (ESPR.US)$ Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry:
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...

10xStockPicks

Dec 14, 2024 21:19

This $2.25 Stock Soon To Turn A Profit Is Highly Likely To Be Acquired Above $10

This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...

NathanRobert

Nov 13, 2024 15:03

5 Quality Stocks That Are Undervalued

🔥 We go over 5 stocks that look undervalued, i show you the numbers for yourself, i own 1 of the stocks on the list, but i try to go over stocks you’ve probably never heard of before! LMK ur thoughts :)
$Hershey (HSY.US)$ $Celsius Holdings (CELH.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $Yelp Inc (YELP.US)$ $Innovative Industrial Properties Inc (IIPR.US)$

https://youtu.be/4qd-58cBqi4

From YouTube